Cargando…

Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator

Cardiac sarcoidosis (CS) predisposes to sudden cardiac death (SCD). Guidelines for implantable cardioverter defibrillators (ICDs) in CS have been issued by the Heart Rhythm Society in 2014 and the American College of Cardiology/American Heart Association/Heart Rhythm Society consortium in 2017. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nordenswan, Hanna-Kaisa, Pöyhönen, Pauli, Lehtonen, Jukka, Ekström, Kaj, Uusitalo, Valtteri, Niemelä, Meri, Vihinen, Tapani, Kaikkonen, Kari, Haataja, Petri, Kerola, Tuomas, Rissanen, Tuomas T., Alatalo, Aleksi, Pietilä-Effati, Päivi, Kupari, Markku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508990/ https://www.ncbi.nlm.nih.gov/pubmed/36000392 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.058120

Ejemplares similares

Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25‐Year Nationwide Cohorts
por: Nordenswan, Hanna‐Kaisa, et al.
Publicado: (2021)

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
por: Lehtonen, Jukka, et al.
Publicado: (2023)

Long-Term Survival and Adverse Events in Cardiac Sarcoidosis
por: Kupari, Markku, et al.
Publicado: (2022)

Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis
por: Pöyhönen, Pauli, et al.
Publicado: (2023)

Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series
por: Ekström, Kaj, et al.
Publicado: (2020)

Magnetic Resonance Imaging as a Predictor of Survival Free of Life‐Threatening Arrhythmias and Transplantation in Cardiac Sarcoidosis
por: Ekström, Kaj, et al.
Publicado: (2016)

Spontaneous coronary artery dissection in cardiac sarcoidosis
por: Kandolin, Riina, et al.
Publicado: (2019)

Electrocardiogram as a predictor of sudden cardiac death in middle-aged subjects without a known cardiac disease()
por: Terho, Henri K., et al.
Publicado: (2018)

Diabetes, glucose tolerance, and the risk of sudden cardiac death
por: Eranti, Antti, et al.
Publicado: (2016)

Electrocardiographic Risk Markers of Cardiac Death: Gender Differences in the General Population
por: Haukilahti, Mira Anette E., et al.
Publicado: (2021)

The challenging diagnosis of isolated cardiac sarcoidosis
por: Kupari, Markku
Publicado: (2022)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Pessimism and the risk for coronary heart disease among middle-aged and older Finnish men and women: a ten-year follow-up study
por: Pänkäläinen, Mikko T., et al.
Publicado: (2015)

Clinical features of Parkinson’s disease patients are associated with therapeutic misconception and willingness to participate in clinical trials
por: Reijula, Emmi, et al.
Publicado: (2017)

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator
por: Skowasch, Dirk, et al.
Publicado: (2018)

Current Advances in CETSA
por: Tolvanen, Tuomas Aleksi
Publicado: (2022)

Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Yalta, Kenan, et al.
Publicado: (2022)

Pessimism and risk of death from coronary heart disease among middle-aged and older Finns: an eleven-year follow-up study
por: Pänkäläinen, Mikko, et al.
Publicado: (2016)

Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator
por: Wan, Chingping, et al.
Publicado: (2013)

Access to MRI for patients with cardiac pacemakers and implantable cardioverter defibrillators
por: Pieri, Christopher, et al.
Publicado: (2021)

Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis
por: Andrié, René, et al.
Publicado: (2017)

Risk Factors Associated With Atrioventricular Block
por: Kerola, Tuomas, et al.
Publicado: (2019)

Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators
por: Cenik, Fadime, et al.
Publicado: (2016)

Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2011)

Time evolution of linearized gauge field fluctuations on a real-time lattice
por: Kurkela, Aleksi, et al.
Publicado: (2016)

Plasmon mass scale and quantum fluctuations of classical fields on a real time lattice
por: Kurkela, Aleksi, et al.
Publicado: (2018)

Pushing the envelope: A drug-coated balloon for left main intervention
por: Uskela, Sanna, et al.
Publicado: (2022)

Intravascular Renal Denervation in Renal Dialysis Patients with Uncontrolled Hypertension: A Case Series of Four Patients
por: Pietilä-Effati, Päivi M., et al.
Publicado: (2018)

Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
por: Wäßnig, Nadine K., et al.
Publicado: (2016)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
por: Kutyifa, Valentina, et al.
Publicado: (2018)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis
por: Nguyen, Elaine, et al.
Publicado: (2018)

Reply to Yalta and Yetkin—Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Duffett, Stephen A., et al.
Publicado: (2022)

Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Excess use of thyroid hormone treatment among patients with fibromyalgia: a cross-sectional study in primary health care
por: Aleksi, Varinen, et al.
Publicado: (2022)

Impact of Cardiac Magnetic Resonance (CMR) on utilization of Implantable-Cardioverter-Defibrillators (ICD) for primary prophylaxis of sudden cardiac death
por: Ertel, Andrew, et al.
Publicado: (2013)

Arrhythmic Sudden Cardiac Death and the Role of Implantable Cardioverter-Defibrillator in Patients with Cardiac Amyloidosis—A Narrative Literature Review
por: Liżewska-Springer, Aleksandra, et al.
Publicado: (2021)

Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death
por: Kuehn, Christian, et al.
Publicado: (2022)

Technical success, clinical efficacy, and insight into the causes of restenosis after the percutaneous coronary intervention of de novo coronary artery lesions using a paclitaxel-coated balloon with citrate ester excipient
por: Tervo, Jerry, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dp58a6dgd18lt0kgmoekueeikf